Amit K. Sachdev
Senior Vice President, Corporate Affairs and Public Policy
Mr. Sachdev joined Vertex in July 2007 and currently serves as our Senior Vice President, Corporate Affairs and Public Policy. In this role, he leads our government affairs, public policy and patient advocacy functions.
Mr. Sachdev came from Biotechnology Industry Organization (BIO) where he served as Executive Vice President, Health. Prior to that, Mr. Sachdev was Deputy Commissioner for Policy at the U.S. Food and Drug Administration (FDA) where he also held several other senior appointments from 2002 through 2005. At FDA, he oversaw the development of all FDA policies, regulations and legislation.
From 1998 to 2002, Mr. Sachdev served as Majority Counsel to the Committee on Energy and Commerce in the U.S. House of Representatives. From 1993 to 1997, Mr. Sachdev practiced law, first at the American Chemistry Council, and then with the law firm of Ropes and Gray. Mr. Sachdev received a B.S from Carnegie Mellon University, and a J.D. from Emory University School of Law.
Amit K. Sachdev
Navigator
At Vertex, innovation is our lifeblood. It’s also a core value of the company. In order to deliver medical innovation to patients, we must be willing to take on great challenges, try new approaches, and navigate difficult or uncharted waters.
To succeed, we are committed to delivering the best science, and to do that we build highly talented research and development teams that attract others to invest in our mission. But we must also foster a regulatory and policy landscape that supports medical innovation and those who pursue it.
In this arena, rarely do we come across neutrality. Laws, regulations, policies, each present an opportunity to dramatically help or hinder our efforts. Leadership in public policy and government affairs is about identifying opportunities for collaboration, building lasting external alliances, and motivating and mobilizing people to take action to help us deliver breakthrough medicines to patients. Every interaction, whether it’s with a patient, a doctor, a global ambassador, a Member of Congress, or a regulatory official, is an opportunity to win support for our cause.